Clinical Trial

Trial Protocol ID USOR 21498_VS-6766-203 *STAR*

Trial Description

A Phase 1/2 Study of Avutometinib (VS-6766) in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) 

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Verastem, Inc.

ClinicalTrials.gov NCT ID

  • NCT05074810